India's Mid-Market May 2026: Fintech, Synbio, and Deeptech Series A/B Deals
Beyond the headline rounds, India's May 2026 mid-market spanned fintech (Sahi $33M), synthetic biology (StrainX $13M), B2B commerce, edtech, and precision manufacturing.
Understanding venture capital market dynamics helps founders time their raises and helps investors spot durable themes. Our market analysis covers deal flow, sector concentration, valuation benchmarks, and geographic shifts across the global startup ecosystem.
Browse market analysis articles for data-driven insight into venture capital trends.
Beyond the headline rounds, India's May 2026 mid-market spanned fintech (Sahi $33M), synthetic biology (StrainX $13M), B2B commerce, edtech, and precision manufacturing.
Stord raised $250M Series F at a $3B valuation in May 2026, scaling its fulfillment network, software, and AI tools for independent brands.
Corgi Insurance stacked a $160M Series B and a $106M Series B1 within weeks in May 2026, reaching a $2.6B valuation for its AI-native insurance platform.
C2i Semiconductors raised a $16.7M Series A extension led by TDK Ventures and Peak XV in May 2026, advancing India's push into semiconductor design.
D2C food brand Anveshan raised ₹121 crore (~$12.7M) Series B led by Vertex Ventures and IFC in May 2026, roughly doubling its valuation on a rural-sourcing model.
Anthropic’s last company valuation is $965B from the May 28, 2026 $65B Series H. August secondary talk (Business Insider: traders as high as $1.5T) is not a company round. Keep Q2 revenue and the $65B July run-rate separate from that mark.